Scotland Launches Industrial Biotech Plans

Bioeconomy & Policy
by
|
January 17, 2014

Doris de Guzman has been covering the oleochemicals – natural fats and oils-based chemicals – market for more than 12 years and spread her beat to inorganics and biofuels. She previously covered specialty chemicals industries such as cosmetics, personal care, household/consumer care products, food & beverages, industrial specialties, nanotechnology, nutrition/supplements, and other niche chemical markets.

This blog post originally appeared on the Green Chemicals Blog on January 14, 2014.

Source: Green Chemicals Blog.

Source: Green Chemicals Blog.

This was announced by Scotland’s main economic development agency, Scottish Enterprise, while I was at the Ecochem conference in Basel, Switzerland, in November last year. Scotland is laying out financing for its growing industrial biotechnology sector. The project, called “The National Plan for Industrial Biotechnology – Towards a Greener, Cleaner 2025″, aims to increase existing industrial biotechnology turnover from £189 million last year to £900 million by 2025.

During Ecochem, I moderated a panel where Scottish Enterprise’s head of chemical sciences, Caroline Strain, talked about the strategies of the chemical sciences industry in Scotland in terms of sustainable manufacturing in the country.

Scotland is said to be currently home to over 40 companies actively involved in industrial biotechnology projects. The Scottish Enterprise aims to position Scotland as an international hub for industrial biotechnology (IB) by helping to increase awareness and uptake of technologies; address skills shortages/barriers to developing IB; scope out the potential of biorefinery/biochemical facilities to make them a reality; and putting up innovation centers to position Scotland as a leading hub for IB innovation.

According to Scottish Enterprise, the global IB market is estimated at £150 billion to £360 billion by 2015. Estimates for the UK IB market range from £4 billion to £12 billion. Some of the industrial biotech companies already residing in the region include Ingenza, Celtic Renewables, Ineos, and ThyssenKrupp. As of 2013, there are about 43 companies in Scotland that are actively involved in IB. The aim is to increase this number to 200 companies by 2025.

Scotland currently has no test, demo, or scale-up facilities, which Scottish Enterprise said limits the opportunity for companies to develop and validate commercial-scale production processes.

Related Articles

No items found.

Scotland Launches Industrial Biotech Plans

by
January 17, 2014

Scotland Launches Industrial Biotech Plans

by
January 17, 2014

Doris de Guzman has been covering the oleochemicals – natural fats and oils-based chemicals – market for more than 12 years and spread her beat to inorganics and biofuels. She previously covered specialty chemicals industries such as cosmetics, personal care, household/consumer care products, food & beverages, industrial specialties, nanotechnology, nutrition/supplements, and other niche chemical markets.

This blog post originally appeared on the Green Chemicals Blog on January 14, 2014.

Source: Green Chemicals Blog.

Source: Green Chemicals Blog.

This was announced by Scotland’s main economic development agency, Scottish Enterprise, while I was at the Ecochem conference in Basel, Switzerland, in November last year. Scotland is laying out financing for its growing industrial biotechnology sector. The project, called “The National Plan for Industrial Biotechnology – Towards a Greener, Cleaner 2025″, aims to increase existing industrial biotechnology turnover from £189 million last year to £900 million by 2025.

During Ecochem, I moderated a panel where Scottish Enterprise’s head of chemical sciences, Caroline Strain, talked about the strategies of the chemical sciences industry in Scotland in terms of sustainable manufacturing in the country.

Scotland is said to be currently home to over 40 companies actively involved in industrial biotechnology projects. The Scottish Enterprise aims to position Scotland as an international hub for industrial biotechnology (IB) by helping to increase awareness and uptake of technologies; address skills shortages/barriers to developing IB; scope out the potential of biorefinery/biochemical facilities to make them a reality; and putting up innovation centers to position Scotland as a leading hub for IB innovation.

According to Scottish Enterprise, the global IB market is estimated at £150 billion to £360 billion by 2015. Estimates for the UK IB market range from £4 billion to £12 billion. Some of the industrial biotech companies already residing in the region include Ingenza, Celtic Renewables, Ineos, and ThyssenKrupp. As of 2013, there are about 43 companies in Scotland that are actively involved in IB. The aim is to increase this number to 200 companies by 2025.

Scotland currently has no test, demo, or scale-up facilities, which Scottish Enterprise said limits the opportunity for companies to develop and validate commercial-scale production processes.

RECENT INDUSTRY NEWS
RECENT INSIGHTS
Sign Up Now